Pathogen distribution and drug resistance in pneumonias among immunocompromised hosts

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To provide evidence for diagnosis and treatment by investigating the pathogens and drug resistance of immunocompromised host (ICH) pneumonias. Methods: Statistical method was used to analyze retrospectively the data of pathogens and drug resistance of ICH pneumonia treated in our hospital in 2014. Results: We confirmed 187 cases of ICH pneumonia by pathogen study of 324 patients. Gram-negative bacillus (68.42%) was the main pathogen of ICH pneumonia. Acinetobacter baumanii (AB) accounted for the first place. Staphylococcus aureus infection was still the first of Gram-positive coccus. Conclusion: Gram-negative bacillus was the main pathogen of ICH pneumonia in our hospital and the isolated bacteria show strong antibiotic resistance. Therefore, it is necessary to strengthen dynamic monitoring of pathogens in the secretions from ICH pneumonia patients' lower respiratory tract and drug resistance. It is suggested that clinicians make anti-infection treatment cover drug-resistant bacteria.

Original languageEnglish
Pages (from-to)423-427 and 431
JournalJournal of Xi'an Jiaotong University (Medical Sciences)
Volume37
Issue number3
DOIs
StatePublished - 5 May 2016

Keywords

  • Drug resistance
  • Immunocompromised host (ICH) pneumonia
  • Pathogenic characteristic
  • Study of pathogen

Fingerprint

Dive into the research topics of 'Pathogen distribution and drug resistance in pneumonias among immunocompromised hosts'. Together they form a unique fingerprint.

Cite this